Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.

NCT03242382 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Soft-tissue Sarcoma
Osteosarcoma
Chordoma

Interventions

DRUG: Palbociclib

Sponsor

Grupo Espanol de Investigacion en Sarcomas